Press Releases
"Prime Time," a Branded Peyronie's Disease Commercial for XIAFLEX® (collagenase clostridium histolyticum)
Mallinckrodt plc Reports Financial Results for Second Quarter 2025 and Provides Guidance
Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader
Endo Presents Plantar Fibromatosis and Plantar Fasciitis Data at the American Podiatric Medical Association Annual Meeting
Endo to Report Second Quarter 2025 Financial Results on August 6, 2025
Mallinckrodt Receives Necessary Ruling from Irish High Court to Combine with Endo, Inc.
Endo Completes International Pharmaceuticals Business Divestiture
Mallinckrodt and Endo Shareholders Approve Combination to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Mallinckrodt, Endo Announce Planned Leadership Team for Merged Company
Endo Champions Men's Health Month with Education, Awareness, and Outreach